A Study on How NNC0174-1213 Works in People With Overweight or Obesity.

Recruiting

Phase 1

A Study on How NNC0174-1213 Works in People With Overweight or Obesity.

Sponsor:

Novo Nordisk A/S

Code:

NCT06719011

Conditions

Obesity

Overweight

Eligibility Criteria

Sex: Male

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

NNC0174-1213 A

Cagrilintide B

Placebo A (NNC0174 1213 A)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information